Biocytogen

Biocytogen

Your Partner From Targets To Therapeutics

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Biocytogen. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
229 people
Headquarters
Waltham, Massachusetts +4 more
Founded
2009
Type
Public Company
Total funding
$335.2M

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.

Preclinical Services Animal Models Gene Targeting Humanized Immune-oncology Checkpoint Mouse Immune-deficient mouse model Antibody Research and Development Animal Production and Breeding In vivo study Fully human antibody mouse Immuno-Oncology Antibody discovery Preclinical CRO

Open roles at Biocytogen